The existence of naturally acquired cellular immunity to CSP is further supported by genetic evidence of variant specific selection pressure among T cell epitopes in CSP [22], [23], and a previously described association between CSP-peptide reactive T cells detected by cultured ELISPOT and protection against malaria in both RTS,S/AS01E vaccinees and control vaccinees [13]. This evidence concerns the gene DNAJC5 and malaria.